Tasha Tsao

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Yan-Ruide Li, Yang Zhou, Yanni Zhu et al. · Cell Reports Medicine · 2021 · 104 citations · Full text

Life Sciences, Immunology, Oncology +17

Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer

Yanni Zhu, Drake J. Smith, Yang Zhou et al. · Cell stem cell · 2019 · 97 citations · Full text

Life Sciences, Hematology, Immunology +10

NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes

Daniel R. Calabrese, Tasha Tsao, Mélia Magnen et al. · JCI Insight · 2022 · 23 citations · Full text

Life Sciences, Immunology, Pathology +14

Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction

Daniel T. Dugger, Daniel R. Calabrese, Ying Gao et al. · Frontiers in Immunology · 2021 · 21 citations · Full text

Medicine, Genetics, Molecular Biology +17

CCR5 drives NK cell–associated airway damage in pulmonary ischemia-reperfusion injury

Jesse Santos, Ping Wang, Avishai Shemesh et al. · JCI Insight · 2023 · 19 citations · Full text

Life Sciences, Immunology, Pathology +17